The move broadens treatment choices for pediatric patients aged 10 years and older whose diabetes remains uncontrolled with ...

Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification. Objectives: To describe ...

Ozempic (injectable semaglutide) is a once-weekly treatment indicated as an add-on to diet and exercise for adults with ...

Gut microbes produce a molecule that switches off inflammation linked to diabetes, offering a surprising new path to metabolic protection.

An international research team has uncovered a surprising ally in the fight against insulin resistance and type 2 diabetes: a ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

Game-changing new medications called GLP-1 agonists and SGLT2 inhibitors can not only control blood sugar but also help people lose weight by making them feel full faster, so they eat less. Why is ...

A recent Cleveland Clinic study used AI to create digital twins of patients' metabolisms—and cured seven in 10 type 2 diabetics.

Eli Lilly's popular drug Mounjaro will be added to China's state-run health insurance scheme from January 1 for patients with ...

This study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice. Conclusions: ...

Finerenone use for 6 months was safe and associated with a significant 25% decrease in albuminuria for adults with type 1 diabetes and chronic kidney disease, according to data presented in the ...